Synthetic BiologybioRxivPreprint
Quantifying the antimicrobial activity of CRISPR-Cas9-accA modified ΔB. subtilis mutants against V. harveyi and E. Coli
This study enhances the antimicrobial activity of B. subtilis by deleting the accA gene using CRISPR-Cas9, but finds reduced antimicrobial activity and increased antibiotic resistance in co-cultures with V. harveyi and E. coli.
DOI 10.1101/2021.08.10.455802